Emergency Treatment of Allergic Reactions in the ER
The first-line treatment for allergic reactions in the emergency room is intramuscular (IM) epinephrine, which should be administered promptly as the cornerstone of management for anaphylaxis. 1
Initial Assessment and Management
Severity Assessment
- Mild reactions: Localized hives, mild itching, mild swelling
- Severe reactions/Anaphylaxis: Any of the following:
- Respiratory symptoms (stridor, wheezing, shortness of breath)
- Cardiovascular symptoms (hypotension, tachycardia)
- Widespread urticaria or angioedema
- GI symptoms (vomiting, diarrhea, abdominal cramps)
- Altered mental status
Immediate Actions for Anaphylaxis
Administer epinephrine IM into the anterolateral thigh 1
Position patient appropriately
- Place in recumbent position with legs elevated if tolerated 1
- This improves venous return and cardiac output
Call for help/activate emergency response system 1
Secondary Interventions
After epinephrine administration, implement these additional measures:
Airway and Breathing
- Provide supplemental oxygen if needed 1
- Monitor oxygen saturation
- For bronchospasm not responding to epinephrine, administer inhaled albuterol 1
Circulation
- Establish IV access
- Administer IV fluids for hypotension (10-20 mL/kg bolus) 1
- Monitor vital signs every 5-15 minutes until stable
Medications (Adjunctive Therapy)
H1 antihistamines (e.g., diphenhydramine 25-50 mg IV/IM/PO) 1, 3
- Note: These are second-line agents and should not replace epinephrine
- Only relieve itching and urticaria, not respiratory symptoms or shock
H2 antihistamines (e.g., ranitidine)
- May be used in combination with H1 antihistamines
- Should not be used without H1 antihistamines 1
Corticosteroids (e.g., methylprednisolone 1-2 mg/kg IV)
- May help prevent biphasic or protracted reactions
- Slow onset of action; not effective for acute symptoms 1
Special Considerations
Refractory Anaphylaxis
- If no response to IM epinephrine and fluid resuscitation:
Monitoring
- Continue monitoring for at least 4-6 hours after symptom resolution
- Longer observation may be needed for severe reactions or those requiring multiple doses of epinephrine 5
- Monitor for biphasic reactions (recurrence of symptoms after initial resolution)
Common Pitfalls to Avoid
- Delaying epinephrine administration - This is associated with increased mortality and morbidity 1
- Using antihistamines or corticosteroids as first-line treatment - These medications do not treat respiratory or cardiovascular symptoms and have a delayed onset of action 1
- Administering epinephrine subcutaneously instead of intramuscularly - IM administration provides more rapid and reliable absorption 1
- Discharging patients too early - Patients should be observed for potential biphasic reactions 4
- Not prescribing epinephrine auto-injectors at discharge - Patients with anaphylaxis should be prescribed auto-injectors and educated on their use 1
Discharge Planning
- Prescribe epinephrine auto-injector(s) 1
- Provide patient education on:
- Proper use of auto-injector
- Allergen avoidance
- Recognition of symptoms
- When to seek emergency care
- Refer to an allergist for follow-up and consideration of immunotherapy if appropriate 1
- Consider multiple epinephrine devices for patients with history of severe anaphylaxis or those who have required multiple doses previously 5